Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
04/2003
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413206A Non peptide tachykinin receptor antagonists
04/23/2003CN1413193A Nitrile derivatives as cathepsin K inhibitors
04/23/2003CN1413190A EP4 receptor selective agonists in treatment of osteoporosis
04/23/2003CN1413186A Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
04/23/2003CN1413109A Substituted acylhydroxamic acids and method of reducing TNF-alpha levels
04/23/2003CN1413105A Novel method of treatment
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1411868A Bone-joining elixir and its preparation method
04/23/2003CN1411865A Medicine for curing reduction of fracture and its production method
04/23/2003CN1411864A High-energy biological vector preparation for expelling cold, promoting blood circulation and removing obatruction in channel and its preparation method
04/23/2003CN1411863A Clematis liquor
04/23/2003CN1411861A Medicine for curing acute injury of muscle and tendon and its preparation method
04/23/2003CN1411856A Displaying and curing liquor for rheumatism
04/23/2003CN1411851A Chinese adhesive plaster for curing rheumatism and hyperosteogeny
04/23/2003CN1411848A Chinese medicine liquor for clearing and activating channels and collaterals
04/23/2003CN1411841A Chinese medicine plaster for external application for curing hyperosteogeny, cervical spondylopathy and prolapse of lumbar intervertebral disk and its preparation method
04/23/2003CN1411840A Chinese medicine for curing hyperosteogeny, cervical spondylopathy and prolapse of lumbar intervertebral disk and its preparation method
04/23/2003CN1411836A Carthamus flower medicated liquor
04/23/2003CN1411829A Medicine for curing proliferation arthritis of spine and its preparation method
04/23/2003CN1106394C Dihydrobenzopyran and dihydrobenzopyran compound and their use
04/23/2003CN1106200C Togluo Ruanjiangao plaster and its preparing method
04/22/2003US6552223 N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them
04/22/2003US6552075 Therapeutic compounds and methods of use
04/22/2003US6552067 EP4 receptor selective agonists in the treatment of osteoporosis
04/22/2003US6552066 Protein tyrosine kinase inhibitors for treating osteoarthritis
04/22/2003US6552054 Chromone derivatives, process for the preparation of the same and uses thereof
04/22/2003US6552041 Cyclized amide derivatives useful for treating or preventing neuronal damage associated with neurological disease
04/22/2003US6552029 For therapy of rheumatoid arthritis, psoriasis, graft v. host disease, asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, complications following percutaneous transluminal coronary angioplasty, thrombosis
04/22/2003US6552019 Inhibitors of p38
04/22/2003CA2253869C Substituted oxobutyric acids as matrix metalloprotease inhibitors
04/17/2003WO2003031939A2 Protein modification and maintenance molecules
04/17/2003WO2003031475A2 Antibodies against kdr, their production and uses
04/17/2003WO2003031464A2 Remodeling and glycoconjugation of peptides
04/17/2003WO2003031447A2 Pyrimidine derivatives
04/17/2003WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003WO2003031438A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003WO2003031437A1 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
04/17/2003WO2003031434A1 Compounds and methods
04/17/2003WO2003031432A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
04/17/2003WO2003031418A1 3,4-dihydro-1h-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor
04/17/2003WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent
04/17/2003WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
04/17/2003WO2003031400A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3
04/17/2003WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003WO2003030944A2 Inhibition of stat-1
04/17/2003WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
04/17/2003WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
04/17/2003WO2003030919A1 Method of obtaining an extract of ginger
04/17/2003WO2003030902A1 Imidazole derivates as anti-inflammatory agents
04/17/2003WO2003030897A1 Pyrrolidinone derivatives
04/17/2003WO2003030889A1 Para-amino benzoic acids as integrin antagonists
04/17/2003WO2003030885A2 Modulation of the adventitial tool-like receptor
04/17/2003WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003WO2003030833A2 Angiopoietin-2 specific binding agents
04/17/2003WO2003030823A2 Combinations for the treatment of immunoinflammatory disorders
04/17/2003WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor
04/17/2003WO2003008457A3 Polysaccharidic esters of retinoic acid
04/17/2003WO2003007922A3 Pharmaceutical formulation containing an ltb4 antagonist
04/17/2003WO2003007875A3 Compounds with analgesic, antipyretic and/or anti-inflammatory activity
04/17/2003WO2003005999A3 Methods of treating cytokine mediated diseases
04/17/2003WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof
04/17/2003WO2002083700A3 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
04/17/2003WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof
04/17/2003WO2002060163A9 Methods for increasing bone formation and enhancing bone accretion
04/17/2003WO2002047704A9 Herbal pharmaceutical compositions for treating immunological disorders
04/17/2003WO2002033085A3 Wisp polypeptides and therapeutical applications thereof
04/17/2003WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
04/17/2003WO2002029036A3 Lipid metabolism enzymes
04/17/2003WO2002024891A3 B7-like molecules and uses thereof
04/17/2003WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
04/17/2003WO2002018575A3 Genes expressed in the cell cycle
04/17/2003WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
04/17/2003WO2001089494A8 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
04/17/2003WO2000002548A3 Inhibitors of proteasomal activity for stimulating bone and hair growth
04/17/2003US20030073857 26,27-Homologated-20-epi-2-alkyl-19-nor-vitamin D compounds
04/17/2003US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
04/17/2003US20030073732 Antiinflammatory agents
04/17/2003US20030073727 Central nervous system disorders
04/17/2003US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens
04/17/2003US20030073720 Tryptase inhibitors
04/17/2003US20030073719 Chiral salt resolution
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073699 Compounds and methods to treat cardiac failure and other disorders
04/17/2003US20030073692 Anticancer agents; viricides; Alzheimer's diseases
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073675 Novel 19-norsteroids substituted in position 11beta, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them
04/17/2003US20030073671 Side effect reduction; hormone replacement therapy
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073218 Enzyme inhibitor for us in the treatment and prevention of tumors
04/17/2003US20030073167 DNA encoding SNORF36 receptors
04/17/2003US20030073123 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition
04/17/2003US20030072756 Combination therapy using an IL-1 inhibitor and methotrexate
04/17/2003DE10139783C1 Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung Cell compositions for the treatment of osteoarthritis, as well as processes for their preparation
04/17/2003CA2463496A1 Method of obtaining an extract of ginger
04/17/2003CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 820